載入...
New features of glatiramer acetate for the treatment of remitting multiple sclerosis
The article discusses usage of the new dosage of glatiramer acetate (Copaxone®) for the treatment of relapsing-remitting multiple sclerosis. Results of phase II and III clinical trials are presented. Randomized clinical trials GALA and GLACIER demonstrated high efficacy, good safety and tolerability...
Na minha lista:
主要作者: | |
---|---|
格式: | Artigo |
語言: | Russo |
出版: |
Remedium Group LLC
2015-12-01
|
叢編: | Медицинский совет |
主題: | |
在線閱讀: | https://www.med-sovet.pro/jour/article/view/273 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|